Peptide Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
91
NCT04313400
Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 10, 2020
Completion: Jan 2, 2024
Loading map...